Sign Up | Log In | What is SocialPicks?

GenProbe Inc (GPRO) Trade Now » Rate GPRO - Discuss GPRO - Add to Watch List

Sector: Technology > Industry: Scientific & Technical Instr.

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate GPRO:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

GPRO Analysis & Videos »

... View All >

GPRO: Bull or Bear?

Gen-Probe (GRPO): Pipeline of profits from genetic testing GPRO

19%

-32.55%
in 199 days

"Gen-Probe Incorporated (NASDAQ: GPRO) creates nucleic acid tests that identify disease-causing agents directly through their genetic fingerprints," says Dave Dyer.

In his Dave Dyer's Newsletter, he explains "The firm's most established market is screening donated blood for HIV and hepatitis viruses. Now, we expect it to be the first to have a gene-based test to detect prostate cancer."

"The current PSA test for prostate cancer --� the most common cancer in men -- is unreliable, in part, because a lot of things other than cancer can affect PSA levels. In addition, men dread the current testi

...

Continue reading »

By The Stock Advisors (-38.37% risk: conservative) 05/20/08

Comment

BUY: Gen-Probe Incorporated (GPRO) GPRO

11%

-27.32%
in 661 days

BUY: Gen-Probe Incorporated (GPRO) $52.07 (2/9/07) Sell price: $54.67 or Sell date: March 16, 2007Stop loss: $49.77 (-4.4%) EMA/MACD very bullishFibonacci analysis bullishStrong bullish 3 day chart pattern with Strong 3 day accumulation.Extreme bullish 1 day moneyflow Profile: Gen-Probe Incorporated (Gen-Probe) is engaged in developing, manufacturing and marketing nucleic [...]

Continue reading »

By fivepercentstocks (-40.63% risk: conservative) 02/13/07

Comment

... View All >

People Bullish on GPRO

The Stock Advisors

Analyst

19%

6 mos ago

Mark T

Analyst

3 %

12 mos ago

Scott Christy

Sr. Analyst

29%

about 1 year ago

Gabriel Kent

Sr. Analyst

25%

about 1 year ago

firefinancial

Analyst

71%

about 1 year ago

People Bearish on GPRO

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	20.58	+45.12%	177
2	Gerald Greene	18.72	+43.19%	57
3	krprasad	16.36	+17.64%	7
4	The Big Bear	15.42	+40.59%	212
5	akiralegrand	13.79	+16.71%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
AMZN	Amazoncom Inc
WM	Washington Mutual Inc
AMD	Advanced Micro Devices Inc
AIG	American International Group Inc.
GOOG	Google Inc
EBAY	eBay Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

STP		Bullish on STP ... by Marian Filo
NEOG		A New Index of Pet & Animal Care Cos. by Mike Havrilla
MO		A More Focused Highly Defensive Index by Mike Havrilla
JLL		Nibbling at a good company by Thomas George
ETP		Cramer special... ETP by Locationh

... more »

Broker Center

Trade GPRO Now
and Get 30 Free Trades »

StreetInsider.com on GPRO

Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference

DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008

Morgan Stanley Downgrades Gen-Probe (GPRO) to Equalweight

Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting

Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About GenProbe Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.